Skip to main content
Fig. 2 | Malaria Journal

Fig. 2

From: Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018

Fig. 2

Therapeutic efficacy study flow chart, Burkina Faso, 2017–2018. RDT: rapid diagnostic test. AL: artemether-lumefantrine. DP: dihydroartemisinin-piperaquine. Danger signs include inability to drink or breastfeed, repeated vomiting (> 2 times in 24 h), convulsions, unconscious state, inability to sit or stand

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us